The ARGOS Biometer, which received FDA clearance in 2019, is currently Alcon’s flagship biometry device. It was developed through a collaboration with MOVU, a company owned by Santec (6777-TYO, Not ...
Alcon Announces Largest-Ever Scientific Presence at ASCRS 2023 and Expands Image-Guided Connectivity
FORT WORTH, Texas--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, will once again have the largest surgical ophthalmic presence at ...
Alcon Inc. ALC is expected to report first-quarter 2023 results shortly. In the last reported quarter, the company’s earnings per share (EPS) of 42 cents were in line with the Zacks Consensus Estimate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results